<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran," exact="Iran" post="Tel/Fax +982126109931 Email tayebehfarhadi@yahoo.com epub: 2020-8-8collection: 20201432153222received: 2020-5-05accepted: 2020-7-17(C)"/>
 <result pre="pharmacokinetics of remdesivir have been summarized in documentation published by" exact="the US" post="Food and Drug Administration (FDA). The FDA has issued"/>
 <result pre="Different Viruses Remdesivir (GS-5734) was developed by Gilead Sciences. Gilead," exact="the US" post="Centers for Disease Control and Prevention (CDC) and the"/>
 <result pre="the US Centers for Disease Control and Prevention (CDC) and" exact="the US" post="Army Medical Research Institute of Infectious Diseases (USAMRIID) collaborated"/>
 <result pre="observed.24 In a controlled, randomized clinical trial conducted in the" exact="Democratic Republic of Congo," post="175 patients were randomly treated with remdesivir for Ebola."/>
 <result pre="In a controlled, randomized clinical trial conducted in the Democratic" exact="Republic of" post="Congo, 175 patients were randomly treated with remdesivir for"/>
 <result pre="new medical research on the first 12 COVID-19 patients in" exact="the USA;" post="however, authors indicated that the study has yet to"/>
 <result pre="trial in adult patients with COVID-19 at ten hospitals in" exact="China" post="(ClinicalTrials.gov number: NCT04257656). The 237 patients were randomly divided"/>
 <result pre="A double-blinded, placebo-controlled trial (ClinicalTrials.gov identifier: NCT04280705) is underway in" exact="the USA" post="in which patients are randomly divided into two placebo"/>
 <result pre="discharged by day 11.38 Two double-blinded, placebo-controlled trials recruiting in" exact="China" post="were designed to evaluate the efficacy and safety of"/>
 <result pre="of remdesivir in hospitalized adult patients with severe COVID-19 Terminated" exact="China" post="April 10, 2020 NCT04365725 A multicenter, retrospective study of"/>
 <result pre="of remdesivir in the treatment of severe COVID-19 infections Recruiting" exact="France" post="June 2020 NCT04302766 An intermediate-size patient population expanded access"/>
 <result pre="in hospitalized adult patients with mild and moderate COVID-19 Suspended" exact="China" post="April 27, 2020 NCT04323761 Expanded access treatment protocol: remdesivir"/>
 <result pre="the Public Health Emergency SOLIDARITY Trial (World Health Organization) Recruiting" exact="Canada" post="May 18, 2022 Up Going Steps Initial findings of"/>
 <result pre="(WHO) has welcomed the initial clinical trial results from the" exact="United Kingdom" post="that showed dexamethasone could reduce mortality by one-third in"/>
 <result pre="LindquistS, et al. First case of 2019 novel coronavirus in" exact="the United States." post="N Engl J Med. 2020;382(10):929â€&quot;936. doi:10.1056/NEJMoa200119132004427 28.collab: The COVID-19"/>
 <result pre="et al. First case of 2019 novel coronavirus in the" exact="United States." post="N Engl J Med. 2020;382(10):929â€&quot;936. doi:10.1056/NEJMoa200119132004427 28.collab: The COVID-19"/>
 <result pre="Team. First 12 Patients with Coronavirus Disease 2019 (COVID-19) in" exact="the United States." post="Preprint; 2020. 29.GreinJ, OhmagariN, ShinD, et al. Compassionate use"/>
 <result pre="First 12 Patients with Coronavirus Disease 2019 (COVID-19) in the" exact="United States." post="Preprint; 2020. 29.GreinJ, OhmagariN, ShinD, et al. Compassionate use"/>
 <result pre="al. First 12 Patients with Coronavirus Disease 2019 (COVID-19) in" exact="the United States." post="medRxiv; 2020. 31.LescureFX, BouadmaL, NguyenD, et al. Clinical and"/>
 <result pre="First 12 Patients with Coronavirus Disease 2019 (COVID-19) in the" exact="United States." post="medRxiv; 2020. 31.LescureFX, BouadmaL, NguyenD, et al. Clinical and"/>
</results>
